FDA Warning Letter Cites Omnicef Contract Manufacturer For GMP Violations
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite an effect on supply, Abbott said Omnicef oral suspension will remain available for patients who rely on the antibiotic.